ALA: Advanced lead cell therapy to Phase 1 trials, narrowing net loss and maintaining strong cash reservesQuartr·Aug 19 at 08:52 PMALA+8.41%
ALA: Off-the-shelf CAR-iNKT therapy nears first patient dosing, targeting broad oncology and autoimmune marketsQuartr·Aug 12 at 01:14 AMALA+8.41%
Astera Labs (ALAB) Is Up 6.7% After Strong AI Connectivity Expectations Ahead Of Q2 Earnings - Has The Bull Case Changed?Simplywall·Aug 2 at 02:28 AMALAB+3.14%LABX+5.82%
AltaGas says Q2 2026 earnings strength comes from higher LPG export volumes, margins and Pipestone II contributionPUBT·Jul 30 at 05:19 AMALA+8.41%
Tourmaline Q2 net earnings drop 64% to CAD 184.43 million; revenue slips 1% to CAD 1.49 billionPUBT·Jul 29 at 04:24 PMALA+8.41%
